Dies 19 i 20 de novembre de 2020 | Online
Inscripcions
Programa
19-11-2020 | Online | Online (Online)
15:30 - 16:00 Arrival, Registration and Documentation delivery
16:00 - 16:15 Welcome to the XIVth CONGRESS of the SCI
| Presentador/a: Dr. Marcos López Hoyos | |
|
President of the SEI |
|
| Presentador/a: Dr. Ricardo Pujol Borrell | |
|
President of the SCI |
|
16:15 - 17:00 Opening Lecture –
Immunological memory against the dogma
| Ponent: Dr. Andreas Radbruch | |
|
Charité, Universitätsmedizin Berlin |
| Moderador/a: Dr. Pablo Engel Rocamora | |
|
University of Barcelona |
17:00 - 17:30 Poster viewing
17:30 - 18:00 Plenary Session: Inter-TCR crosstalk during antigen recognition.
| Ponent: Dr. Balbino Alarcón | |
|
Centro Biología Molecular Severo Ochoa, Madrid |
|
| Moderador/a: Dra. Annabel Valledor | |
|
University of Barcelona |
|
18:00 - 19:45 Oral Communications, Session-1 – Basic and Experimental Immunology
| Moderador/a: Dr. Winfried Pickl | |
|
Medical University of Vienna |
|
Experimental and genetic evidence for the involvement of CD6 in inflammatory bowel diseases.
| Ponent: Dr. Sergi Casadó Llombar | |
|
et al. |
Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production
| Ponent: Dr. Antonio Celada | |
|
et al. |
Immunomodulation of type 1 diabetes by 116C-NOD intestinal microbiota
| Ponent: Dra. Estela Rosell Mases | |
|
et al. |
siRNA-containing transfection of vitamin D3-induced tolerogenic dendriticcells for the silencing of potential tolerogenic genes
| Ponent: Dr. Íñigo González Larreategui | |
|
et al. |
Immunomodulatory properties of a soluble cytomegalovirus-encoded CD48 Homolog.
| Ponent: Dr. Francesc Poblador | |
|
et al. |
MRL mice infected with cytomegalovirus (CMV) as an animal model of Sjögren’s Syndrome.
| Ponent: Dr. Joan Puñet Ortiz | |
|
et al. |
HIV-1 enveloped Virus-Like Particles (VLP) displaying high density of HIV-1 Env-derived antigens on their surface induce a functional immune response beyond neutralizing activity
| Ponent: Dr. Ferran Tarrés Freixas | |
|
et al. |
19:25 - 19:45 Discussion (Oral Communications, Session-1 – Basic and Experimental Immunology)
19:45 - 20:15 Plenary Session: The role of a new T helper cell type, Th-IL-2 cells, in allergic immune reactions
| Moderador/a: Dra. Eva Maria Martinez Carceres | |
|
Autonomus University of Barcelona |
|
| Ponent: Dr. Winfried Pickl | |
|
Medical University of Vienna |
|
20-11-2020 | Online | Online (Online)
08:30 - 09:00 Arrival, Registration and Documentation delivery
09:00 - 09:30 Plenary Session: Tissue memory cells at the center of the immune system
| Ponent: Dr. René Van Lier | |
|
Sanquin Blood Supply. University of Amsterdam |
|
| Moderador/a: Dra. Dolores Jaraquemada Perez de Guzmán | |
|
Autonomous University of Barcelona |
|
09:30 - 10:00 Plenary Session: Development of humen “adaptive” NK cell populations: open issues.
| Moderador/a: Dr. Miguel López Botet | |
|
University Pompeu Fabra, Barcelona |
|
| Moderador/a: Dr. Pablo Engel Rocamora | |
|
University of Barcelona |
|
10:00 - 11:30 Oral Communications, Session 2: Clinical Immunology I
| Moderador/a: Dra. Cristina Costa Vallès | |
|
(IDIBELL, Barcelona |
|
| Moderador/a: Dra. Mª Rosa Faner Canet | |
|
Hospital Clinic, Barcelona |
|
Changes induced in lymphocyte subpopulations by dimethyl-fumarate treatment in multiple sclerosis could identify “NEDA” patients.
| Ponent: Dra. Aina Teniente Serra | |
|
et al. |
Lymphocyte subpopulations analysis in psoriatic patients treated with biological drugs
| Ponent: Dr. Marc Boigues Pons | |
|
et al. |
Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the effect of Maintenance Immunotherapy
| Ponent: Dra. María Iglesias Escudero | |
|
et al. |
Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients
| Ponent: Dra. Michelle Ataya | |
|
et al. |
Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
| Ponent: Dra. Tamara Cruz | |
|
et al. |
Immunophenotype in CU patients under omalizumab treatment.
| Ponent: Dra. Cristina Alejandra López Rodriguez | |
11:30 - 12:00 Plenary Session: Conventional and unconventional T cell response to microbial antigens.
| Ponent: Dra. Federica Sallusto | |
|
Institute for Research in Biomedicine Bellinzona |
|
| Moderador/a: Dr. Ricardo Pujol Borrell | |
|
Autonomous University of Barcelona |
|
12:00 - 13:00 Ordinary General Meeting- Societat Catalana d’Immunologia
13:00 - 13:30 Poster viewing
13:30 - 14:00 Lunch session sponsored by Becton Dickinson.Resolving immune cell identity one cell at time. The multiomic approach.
| Ponent: Dr. Werner Rodriguez | |
|
BD Biosciences | Single Cell Multiomics |
|
14:30 - 16:15 Oral Communications, Session 3: Tumor Immunology and Immunotherapy
| Moderador/a: Dr. Manel Juan Otero | |
|
Hospital Clinic. Barcelona |
|
Phase I multicenter clinical trial with chimeric antigen receptor with humanized anti-BCMA specific ( ARI0002h) in patients with relapsed or refractory multiple myeloma
| Ponent: Dra. Mariona Pascal Capdevila | |
|
et al. |
CART19-BE-01: un ensayo académico Europeo sobre la administración de células CAR-T denominadas ARI-0001 en pacientes con trastornos linfoproliferativos CD19+.
| Ponent: Dr. Valentín Ortiz Maldonado | |
|
et al. |
Humoral immune response in patients with CD19 positive relapsed/refractory B-cell malignances recruited into the CART19-BE-01 clinical trial
| Ponent: Dra. Ariadna Bartoló Ibars | |
|
et al. |
Comparative analysis and characterization of TCR repertoires in breast cancer TILs
| Ponent: Dra. Andrea Aran Garriga | |
|
et al. |
HAVCR2 mutations altering TIM-3 underlying hemophagocytic syndrome and subcutaneous panniculitis-like T-cell lymphoma.
| Ponent: Dr. Roger Colobran Oriol | |
|
et al. |
Dynamics of T-cell subsets in non-small cell lung cancer patients treated with PD-1/PD-L1 axis blocking mAbs
| Ponent: Dra. Coral Zurera Egea | |
|
et al. |
NK cell receptors and ligand variants modulate response to tyrosine kinaseinhibitors in patients with chronic myeloid leukemia
| Ponent: Dra. Laia Closa Gil | |
|
et al. |
15:55 - 16:15 Discussion (Oral Communications, Session 3: Tumor Immunology and Immunotherapy)
16:15 - 16:45 Plenary Session: Unconventional receptor-based antibodies
| Moderador/a: Dr. Miguel López Botet | |
|
(University Pompeu Fabra , Barcelona |
|
| Ponent: Dr. Antonio Lanzavecchia | |
|
National Institute of Molecular Genetics, Milan |
|
16:45 - 18:00 Oral Communications, Session 4: COVID-19
| Moderador/a: Dra. Silvia Vidal Alcorisa | |
|
Santa Creu i Sant Pau Hospital, Barcelona |
|
Early S2-targeting and rapid development of neutralizing antibodies after SARS-CoV-2 infection.
| Moderador/a: Dra. Maria Luisa Rodriguez de la Concepción | |
|
et al. |
Antigen-specific lymphocyte proliferation against SARS-CoV-2 in COVID patients with negative antibodies against the virus in serum
| Ponent: Dra. Marc Boigues Pons | |
|
et al. |
Immunological Risk Profile in COVID-19, the Experience of a Single Academic Hospital in Catalonia.
| Ponent: Dr. Manuel Hernández González | |
|
et al. |
Immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome: overlap with Kawasaki disease and identification of a distinct severe group
| Ponent: Dra. Ana Esteve Solé | |
|
et al. |
Revealing protective T cell immune responses against SARS-CoV-2.
| Ponent: Dra. Judith Grau Expósito | |
|
et al. |
Inborn errors and autoantibodies against type-I inteferons in patients with life-threatening COVID-19.
| Ponent: Dr. Roger Colobran Oriol | |
|
et al. |
17:45 - 18:00 Discussion.(Oral Communications, Session 4: COVID-19)
18:00 - 18:15 Prize to the best communication and poster
| Ponent: Dr. Ricardo Pujol Borrell | |
|
(President of SCI |
|
18:15 - 18:30 Closing of the Congress
| Presentador/a: Dr. Ricardo Pujol Borrell | |
|
(President of SCI |
|